Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Zealand Pharma A/S (ZLDPF : OTC)

• Company Description    Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines. The company's pipeline includes ZP4207, single-dose rescue treatment for acute, severe hypoglycemia; ZP1848 for short bowel syndrome and ZP4207, multiple-dose version intended for use in a dual-hormone artificial pancreas system for better hypoglycemia control and diabetes management and other earlier-stage clinical and preclinical peptide therapeutics are in clinical stage. Zealand Pharma A/S is based in Copenhagen, Denmark. Number of Employees: 335

• Price / Volume Information    Yesterday's Closing Price: $57.00 Daily Weekly Monthly 20 Day Moving Average: 2,453 shares Shares Outstanding: 71.02 (millions) Market Capitalization: $4,048.37 (millions) Beta: 0.72 52 Week High: $101.29 52 Week Low: $49.98 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -15.87% -14.77% 12 Week -26.72% -26.95% Year To Date -20.39% -21.12%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Sydmarken 11 Soborg - Copenhagen,G7 2860 DNK ph: 45-8877-3600 fax: 45-8877-3898 investors@zealandpharma.com http://www.zealandpharma.com

• General Corporate Information    Officers Adam Steensberg - Chief Executive Officer and President Martin Nicklasson - Chairman of the Board of Directors Ivan Moller - Executive Vice President;Chief Operating Officer Henriette Wennicke - Executive Vice President and Chief Financial Offic Bernadette Connaughton - Director Peer Information Zealand Pharma A/S (CORR.) Zealand Pharma A/S (RSPI) Zealand Pharma A/S (CGXP) Zealand Pharma A/S (BGEN) Zealand Pharma A/S (GTBP) Zealand Pharma A/S (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: K9898X127 SIC: 8880 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/14/26 Share - Related Items Shares Outstanding: 71.02 Most Recent Split Date: (:1) Beta: 0.72 Market Capitalization: $4,048.37 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-1.57 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $2.79 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/14/26

• Fundamental Ratios P/E Current FY Estimate: 20.47 Trailing 12 Months: 4.17 PEG Ratio: - Price Ratios Price/Book: 1.70 Price/Cash Flow: - Price / Sales: 2.89 EPS Growth vs. Year Ago Period: -37.29% vs. Previous Quarter: 10.00% Sales Growth vs. Year Ago Period: 729.50% vs. Previous Quarter: 38.37% ROE 12/31/25 - 49.76 09/30/25 - 55.76 06/30/25 - 67.06 ROA 12/31/25 - 45.11 09/30/25 - 50.55 06/30/25 - 61.12 Current Ratio 12/31/25 - - 09/30/25 - 14.10 06/30/25 - 15.09 Quick Ratio 12/31/25 - - 09/30/25 - 14.10 06/30/25 - 15.08 Operating Margin 12/31/25 - 70.06 09/30/25 - 71.79 06/30/25 - 73.90 Net Margin 12/31/25 - 70.06 09/30/25 - 71.79 06/30/25 - 73.90 Pre-Tax Margin 12/31/25 - - 09/30/25 - 78.08 06/30/25 - 79.78 Book Value 12/31/25 - - 09/30/25 - 33.43 06/30/25 - 33.43 Inventory Turnover 12/31/25 - - 09/30/25 - 0.17 06/30/25 - -0.65 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.02 06/30/25 - 0.02 Debt-to-Capital 12/31/25 - - 09/30/25 - 1.93 06/30/25 - 1.85

Powered by Zacks Investment Research ©